Alnylam Pharmaceuticals, Inc. (ALNY)
232.95
-6.05
(-2.53%)
USD |
NASDAQ |
Aug 27, 11:38
Alnylam Pharmaceuticals Price : 232.95 for Aug. 27, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 26, 2026 | 238.54 | 242.89 | 236.60 | 239.00 | 1.116M |
| Aug 25, 2026 | 236.56 | 240.67 | 235.41 | 240.08 | 1.576M |
| Aug 24, 2026 | 235.83 | 237.90 | 228.59 | 236.01 | 2.137M |
| Aug 21, 2026 | 228.88 | 238.97 | 228.34 | 236.22 | 1.906M |
| Aug 20, 2026 | 239.00 | 240.88 | 228.74 | 229.30 | 1.702M |
| Aug 19, 2026 | 234.36 | 244.03 | 233.40 | 242.61 | 1.879M |
| Aug 18, 2026 | 226.27 | 230.91 | 222.01 | 228.61 | 1.600M |
| Aug 17, 2026 | 225.76 | 227.99 | 222.12 | 224.60 | 1.539M |
| Aug 14, 2026 | 223.52 | 228.98 | 220.23 | 228.65 | 1.526M |
| Aug 13, 2026 | 225.95 | 227.54 | 222.70 | 227.12 | 1.449M |
| Aug 12, 2026 | 219.00 | 224.66 | 219.00 | 223.95 | 1.621M |
| Aug 11, 2026 | 217.41 | 223.44 | 216.50 | 221.20 | 1.438M |
| Aug 10, 2026 | 218.00 | 223.50 | 215.61 | 216.98 | 1.405M |
| Aug 07, 2026 | 217.31 | 219.64 | 210.49 | 219.20 | 1.736M |
| Aug 06, 2026 | 228.58 | 234.00 | 212.98 | 216.12 | 2.275M |
| Aug 05, 2026 | 221.74 | 229.65 | 221.50 | 228.72 | 2.735M |
| Aug 04, 2026 | 220.33 | 222.58 | 215.07 | 219.00 | 3.108M |
| Aug 03, 2026 | 208.04 | 220.49 | 208.04 | 220.33 | 3.400M |
| Jul 31, 2026 | 205.46 | 207.99 | 200.11 | 205.52 | 4.478M |
| Jul 30, 2026 | 225.02 | 230.00 | 197.81 | 205.48 | 9.836M |
| Jul 29, 2026 | 288.09 | 290.60 | 284.15 | 286.62 | 1.302M |
| Jul 28, 2026 | 282.79 | 290.47 | 281.22 | 288.41 | 1.438M |
| Jul 27, 2026 | 272.66 | 284.68 | 272.66 | 278.40 | 1.410M |
| Jul 24, 2026 | 268.74 | 275.58 | 265.64 | 271.77 | 1.151M |
| Jul 23, 2026 | 265.95 | 269.22 | 262.21 | 268.74 | 1.141M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ionis Pharmaceuticals, Inc. | 62.91 |
| Regeneron Pharmaceuticals, Inc. | 815.35 |
| Vertex Pharmaceuticals, Inc. | 549.09 |
| BridgeBio Pharma, Inc. | 78.51 |
| Pfizer Inc. | 28.09 |
Price Related Metrics
| PE Ratio | 39.33 |
| PS Ratio | 6.669 |
| Price to Book Value | 23.01 |
| Price to Free Cash Flow | 40.35 |
| Earnings Yield | 2.54% |
| Market Cap | 31.15B |
| Operating PE Ratio | 32.05 |
| Normalized PE Ratio | 40.47 |